LQDA

LiquidiaB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

LQDA vs peer average

80/100

LQDA vs. peer average (B vs. D)

Grade spread

B 1 · C 1 · D 4 · F 2

Graded peers loaded

Coverage

8 graded

100% of tracked

Peer overview

BLTE is the first available peer comparator.

Same-sector market-cap neighbor, but direct operating comparability with Liquidia's commercial inhaled treprostinil franchise is not established; low-confidence reference.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerBLTEBelite Bio

LQDA

Liquidia

BLTE

Belite Bio

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs BLTE

LQDA / BLTE

Grade Position

Above peers

LQDA vs. peer average (B vs. D)

80/100

Momentum

BLTE

Value

LQDA

Sentiment

LQDA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs LQDA

BLTE

40/100

CGON

40/100

GRFS

Grifols SA Class B ADR

60/100

COGT

Cogent Biosciences Inc Common

20/100

MIRM

Mirum Pharmaceuticals Inc Common

80/100

Even

BLTE is the first peer returned for this comparison set.